BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28115215)

  • 1. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.
    Kaustio M; Haapaniemi E; Göös H; Hautala T; Park G; Syrjänen J; Einarsdottir E; Sahu B; Kilpinen S; Rounioja S; Fogarty CL; Glumoff V; Kulmala P; Katayama S; Tamene F; Trotta L; Morgunova E; Krjutškov K; Nurmi K; Eklund K; Lagerstedt A; Helminen M; Martelius T; Mustjoki S; Taipale J; Saarela J; Kere J; Varjosalo M; Seppänen M
    J Allergy Clin Immunol; 2017 Sep; 140(3):782-796. PubMed ID: 28115215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pathogenic Missense Variant in
    Fliegauf M; Krüger R; Steiner S; Hanitsch LG; Büchel S; Wahn V; von Bernuth H; Grimbacher B
    Front Immunol; 2021; 12():621503. PubMed ID: 33995346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.
    Lorenzini T; Fliegauf M; Klammer N; Frede N; Proietti M; Bulashevska A; Camacho-Ordonez N; Varjosalo M; Kinnunen M; de Vries E; van der Meer JWM; Ameratunga R; Roifman CM; Schejter YD; Kobbe R; Hautala T; Atschekzei F; Schmidt RE; Schröder C; Stepensky P; Shadur B; Pedroza LA; van der Flier M; Martínez-Gallo M; Gonzalez-Granado LI; Allende LM; Shcherbina A; Kuzmenko N; Zakharova V; Neves JF; Svec P; Fischer U; Ip W; Bartsch O; Barış S; Klein C; Geha R; Chou J; Alosaimi M; Weintraub L; Boztug K; Hirschmugl T; Dos Santos Vilela MM; Holzinger D; Seidl M; Lougaris V; Plebani A; Alsina L; Piquer-Gibert M; Deyà-Martínez A; Slade CA; Aghamohammadi A; Abolhassani H; Hammarström L; Kuismin O; Helminen M; Allen HL; Thaventhiran JE; Freeman AF; Cook M; Bakhtiar S; Christiansen M; Cunningham-Rundles C; Patel NC; Rae W; Niehues T; Brauer N; Syrjänen J; Seppänen MRJ; Burns SO; Tuijnenburg P; Kuijpers TW; ; Warnatz K; Grimbacher B;
    J Allergy Clin Immunol; 2020 Oct; 146(4):901-911. PubMed ID: 32278790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and Neutrophil Oxidative Burst in a Family with NFKB1 p.R157X LOF and Sterile Necrotizing Fasciitis.
    Santaniemi W; Åström P; Glumoff V; Pernaa N; Tallgren EN; Palosaari S; Nissinen A; Kaustio M; Kuismin O; Saarela J; Nurmi K; Eklund KK; Seppänen MRJ; Hautala T
    J Clin Immunol; 2023 Jul; 43(5):1007-1018. PubMed ID: 36892687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental
    Fliegauf M; Kinnunen M; Posadas-Cantera S; Camacho-Ordonez N; Abolhassani H; Alsina L; Atschekzei F; Bogaert DJ; Burns SO; Church JA; Dückers G; Freeman AF; Hammarström L; Hanitsch LG; Kerre T; Kobbe R; Sharapova SO; Siepermann K; Speckmann C; Steiner S; Verma N; Walter JE; Westermann-Clark E; Goldacker S; Warnatz K; Varjosalo M; Grimbacher B
    Front Immunol; 2022; 13():965326. PubMed ID: 36105815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae.
    Tuovinen EA; Kuismin O; Soikkonen L; Martelius T; Kaustio M; Hämäläinen S; Viskari H; Syrjänen J; Wartiovaara-Kautto U; Eklund KK; Saarela J; Varjosalo M; Kere J; Hautala T; Seppänen MRJ
    Clin Immunol; 2023 Jan; 246():109181. PubMed ID: 36356849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
    Boztug H; Hirschmugl T; Holter W; Lakatos K; Kager L; Trapin D; Pickl W; Förster-Waldl E; Boztug K
    J Clin Immunol; 2016 Aug; 36(6):533-40. PubMed ID: 27338827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in
    Anim M; Sogkas G; Schmidt G; Dubrowinskaja N; Witte T; Schmidt RE; Atschekzei F
    Front Immunol; 2021; 12():767188. PubMed ID: 35003082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.
    Tuijnenburg P; Lango Allen H; Burns SO; Greene D; Jansen MH; Staples E; Stephens J; Carss KJ; Biasci D; Baxendale H; Thomas M; Chandra A; Kiani-Alikhan S; Longhurst HJ; Seneviratne SL; Oksenhendler E; Simeoni I; de Bree GJ; Tool ATJ; van Leeuwen EMM; Ebberink EHTM; Meijer AB; Tuna S; Whitehorn D; Brown M; Turro E; Thrasher AJ; Smith KGC; Thaventhiran JE; Kuijpers TW;
    J Allergy Clin Immunol; 2018 Oct; 142(4):1285-1296. PubMed ID: 29477724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of
    Somma D; Kok FO; Kerrigan D; Wells CA; Carmody RJ
    Front Immunol; 2021; 12():669906. PubMed ID: 34721373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired and Innate Immunity Impairment and Severe Disseminated
    Gonzalez-Granado LI; Ruiz-García R; Blas-Espada J; Moreno-Villares JM; Germán-Diaz M; López-Nevado M; Paz-Artal E; Toldos O; Rodriguez-Gil Y; de Inocencio J; Domínguez-Pinilla N; Allende LM
    Front Immunol; 2018; 9():3148. PubMed ID: 30761159
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined immunodeficiency caused by a novel homozygous NFKB1 mutation.
    Mandola AB; Sharfe N; Nagdi Z; Dadi H; Vong L; Merico D; Ngan B; Reid B; Roifman CM
    J Allergy Clin Immunol; 2021 Feb; 147(2):727-733.e2. PubMed ID: 32980423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFKB1: a suppressor of inflammation, ageing and cancer.
    Cartwright T; Perkins ND; L Wilson C
    FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.
    Li J; Lei WT; Zhang P; Rapaport F; Seeleuthner Y; Lyu B; Asano T; Rosain J; Hammadi B; Zhang Y; Pelham SJ; Spaan AN; Migaud M; Hum D; Bigio B; Chrabieh M; Béziat V; Bustamante J; Zhang SY; Jouanguy E; Boisson-Dupuis S; El Baghdadi J; Aimanianda V; Thoma K; Fliegauf M; Grimbacher B; Korganow AS; Saunders C; Rao VK; Uzel G; Freeman AF; Holland SM; Su HC; Cunningham-Rundles C; Fieschi C; Abel L; Puel A; Cobat A; Casanova JL; Zhang Q; Boisson B
    J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34473196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations.
    Dieli-Crimi R; Martínez-Gallo M; Franco-Jarava C; Antolin M; Blasco L; Paramonov I; Semidey ME; Álvarez Fernández A; Molero X; Velásquez J; Martín-Nalda A; Pujol-Borrell R; Colobran R
    Clin Immunol; 2018 Oct; 195():49-58. PubMed ID: 30063981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variable immunodeficiency in two kindreds with heterogeneous phenotypes caused by novel heterozygous
    Staels F; De Keukeleere K; Kinnunen M; Keskitalo S; Lorenzetti F; Vanmeert M; Prezzemolo T; Pasciuto E; Lescrinier E; Bossuyt X; Gerbaux M; Willemsen M; Neumann J; Van Loo S; Corveleyn A; Willekens K; Stalmans I; Meyts I; Liston A; Humblet-Baron S; Seppänen M; Varjosalo M; Schrijvers R
    Front Immunol; 2022; 13():973543. PubMed ID: 36203612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.
    Hargreaves CE; Dhalla F; Patel AM; de Oteyza ACG; Bateman E; Miller J; Anzilotti C; Ayers L; Grimbacher B; Patel SY
    Clin Immunol; 2022 Jan; 234():108910. PubMed ID: 34922003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-κB1 p105.
    Yang HT; Papoutsopoulou S; Belich M; Brender C; Janzen J; Gantke T; Handley M; Ley SC
    Mol Cell Biol; 2012 Sep; 32(17):3438-51. PubMed ID: 22733995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
    Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
    Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian diseases of dysregulated canonical NF-κB signaling: From immunodeficiency to inflammation.
    Schnappauf O; Aksentijevich I
    J Leukoc Biol; 2020 Aug; 108(2):573-589. PubMed ID: 32678922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.